These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17369777)

  • 1. [Immunological properties of the Gram-negative bacilli Pseudomonas aeruginosa].
    Rusiecka-Ziółkowska J; Fleischer M; Staroszczyk J
    Postepy Hig Med Dosw (Online); 2007; 61():95-8. PubMed ID: 17369777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fish oils on the outcomes of a mouse model of acute Pseudomonas aeruginosa pulmonary infection.
    Caron E; Desseyn JL; Sergent L; Bartke N; Husson MO; Duhamel A; Gottrand F
    Br J Nutr; 2015 Jan; 113(2):191-9. PubMed ID: 25564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.
    Lin CK; Kazmierczak BI
    J Innate Immun; 2017; 9(3):250-261. PubMed ID: 28222444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
    Döring G
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice.
    Carrigan SO; Junkins R; Yang YJ; Macneil A; Richardson C; Johnston B; Lin TJ
    J Immunol; 2010 Sep; 185(6):3602-9. PubMed ID: 20720199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basis for the potential production of immune preparations against Pseudomonas aeruginosa from the blood of convalescent burn patients].
    Povstianoĭ NE; Kolker II; Nazarchuk LV; Fedorovskaia EA; Litovchenko PP
    Gematol Transfuziol; 1984 Jul; 29(7):56-8. PubMed ID: 6205938
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piceatannol modulates lung epithelial cellular responses to Pseudomonas aeruginosa.
    Aval PS; Werner J; Cerqueira A; Balfour-Boehm J; Ulanova M
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):297-307. PubMed ID: 23713607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitization to Pseudomonas aeruginosa in thermal burn patients].
    Kolker II; Minkina AE; Fradkin VA; Panova IuM; Morozov SS
    Klin Med (Mosk); 1982 Jun; 60(6):103-7. PubMed ID: 6811796
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological determinants of pseudomonas infections of man accompanying severe burn injury.
    Alexander JW; Fisher MW
    J Trauma; 1970 Jul; 10(7):565-74. PubMed ID: 4986708
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.
    Saelinger CB; Snell K; Holder IA
    J Infect Dis; 1977 Oct; 136(4):555-61. PubMed ID: 409788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
    Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune surveillance mechanisms of the skin against the stealth infection strategy of Pseudomonas aeruginosa-review.
    Andonova M; Urumova V
    Comp Immunol Microbiol Infect Dis; 2013 Sep; 36(5):433-48. PubMed ID: 23602428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice.
    O'Sullivan R; Carrigan SO; Marshall JS; Lin TJ
    Immunobiology; 2008; 213(6):469-79. PubMed ID: 18514749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bovine innate immune response during experimentally-induced Pseudomonas aeruginosa mastitis.
    Bannerman DD; Chockalingam A; Paape MJ; Hope JC
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):201-15. PubMed ID: 15970335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane CD14, but not soluble CD14, is used by exoenzyme S from P. aeruginosa to signal proinflammatory cytokine production.
    Berenger BM; Hamill J; Stack D; Montgomery E; Huston SM; Timm-McCann M; Epelman S; Mody CH
    J Leukoc Biol; 2011 Jul; 90(1):189-98. PubMed ID: 21498585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.